Iht Wealth Management, LLC Kaleido Biosciences, Inc. Transaction History

Iht Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.05 - $1.7 $944 - $32,113	-18,890 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.39 - $6.02 $3,059 - $7,705	-1,280 Reduced 6.35%	18,890 $45,000
Q3 2021 Nov 15, 2021	BUY	$5.36 - $7.99 $4,556 - $6,791	850 Added 4.4%	20,170 $110,000
Q2 2021 Aug 16, 2021	BUY	$5.82 - $8.72 $112,442 - $168,470	19,320 New	19,320 $144,000
Q1 2020 May 13, 2020	SELL	$3.62 - $9.49 $48,508 - $127,166	-13,400 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$5.02 - $8.87 $12,298 - $21,731	2,450 Added 22.37%	13,400 $67,000
Q3 2019 Nov 15, 2019	BUY	$6.74 - $11.3 $73,803 - $123,735	10,950 New	10,950 $82,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.